LABCORP DRUG DEVELOPMENT H-1B Visa Sponsorship & Salary Data

The median H-1B salary at LABCORP DRUG DEVELOPMENT is $122,000, based on 28 certified filings from FY 2021 to FY 2023. This is 2% higher than the national H-1B median salary of $120,000. Compensation at LABCORP DRUG DEVELOPMENT reflects their market positioning, with entry-level roles starting around $113,000 and senior positions reaching $150,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at LABCORP DRUG DEVELOPMENT range from $94,702 at the 10th percentile to $150,000 at the 90th percentile, showing a $55,298 spread across experience levels and roles. The 25th percentile is $113,000 and the 75th percentile is $138,000.

Yes, LABCORP DRUG DEVELOPMENT actively sponsors H-1B visas in FY 2023. In the most recent fiscal year (FY 2023), LABCORP DRUG DEVELOPMENT filed 5 H-1B labor condition applications with 4 certified and 0 denied, at a median salary of $97,000. Across FY 2021–2023, they have filed 30 total H-1B applications with 28 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. LABCORP DRUG DEVELOPMENT sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2023), LABCORP DRUG DEVELOPMENT filed 5 H-1B applications, with 4 certified and 0 denied. Over 3 years of data, LABCORP DRUG DEVELOPMENT has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

LABCORP DRUG DEVELOPMENT's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 30 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating LABCORP DRUG DEVELOPMENT as a potential H-1B sponsor.

This is an excellent approval rate, indicating LABCORP DRUG DEVELOPMENT has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

LABCORP DRUG DEVELOPMENT sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 28 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles LABCORP DRUG DEVELOPMENT most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at LABCORP DRUG DEVELOPMENT:

The most frequently sponsored role is Senior Statistical Programmer with 8 filings at a median salary of $114,000. This is followed by Principal Statistical Programmer (4 filings) and Principal Stats Programmer.

LABCORP DRUG DEVELOPMENT's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where LABCORP DRUG DEVELOPMENT sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top LABCORP DRUG DEVELOPMENT H-1B locations:

The largest H-1B hub for LABCORP DRUG DEVELOPMENT is Durham, NC with 7 filings at a median salary of $127,000. The highest-paying location is Cary, NC at $150,000 median. Salaries range from $90,189 to $150,000 across office locations.

LABCORP DRUG DEVELOPMENT's median H-1B salary has changed by -20% from FY 2021 ($122,000) to FY 2023 ($97,000). Tracking salary trends over time reveals how LABCORP DRUG DEVELOPMENT adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at LABCORP DRUG DEVELOPMENT.

Year-by-year breakdown:

• FY 2021: $122,000 (5 certified)
• FY 2022: $126,100 (19 certified)
• FY 2023: $97,000 (4 certified)

Salary levels have remained relatively stable at LABCORP DRUG DEVELOPMENT.

LABCORP DRUG DEVELOPMENT primarily files H-1B applications at Wage Level III, accounting for 46% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making LABCORP DRUG DEVELOPMENT's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 89% of positions at Level II or higher, LABCORP DRUG DEVELOPMENT typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

LABCORP DRUG DEVELOPMENT's median H-1B salary of $122,000 is 2% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating LABCORP DRUG DEVELOPMENT's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare LABCORP DRUG DEVELOPMENT's offerings with similar companies in your field for a more accurate assessment.

LABCORP DRUG DEVELOPMENT offers above-average H-1B compensation. Combined with their 28 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. LABCORP DRUG DEVELOPMENT's higher proportion of Level III-IV positions (79%) may benefit from wage-based lottery prioritization.

With 28 certified filings, LABCORP DRUG DEVELOPMENT invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.